Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCND1 | P24385 | 17/20 | 1.00 |
| ▸ | CDK6 | Q00534 | 12/20 | 1.00 |
| ▸ | CDK4 | P11802 | 6/20 | 0.60 |
| ▸ | DYRK2 | Q92630 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24322965 | 0.91 | CCND1 (1.00) | CCND1CDK6CDK4DYRK2 | |
| SCHEMBL25283091 | 0.83 | CCND1 (1.00) | CCND1CDK6CDK4 | |
| SCHEMBL29497098 | 0.83 | CCND1 (1.00) | CCND1CDK6CDK4 | |
| SCHEMBL29514983 | 0.79 | CCND1 (0.73) | CCND1CDK6CDK4DYRK2 | |
| SCHEMBL24322113 | 0.79 | CCND1 (0.73) | CCND1CDK6CDK4DYRK2 | |
| SCHEMBL24322147 | 0.79 | CCND1 (0.81) | CCND1CDK6CDK4 | |
| SCHEMBL19231733 | 0.77 | CDK6 (0.62) | CCND1CDK6CDK4DYRK2 | |
| SCHEMBL17489238 | 0.77 | CDK6 (0.74) | CCND1CDK6CDK4DYRK2 | |
| SCHEMBL25235412 | 0.77 | CCND1 (0.87) | CCND1CDK6CDK4DYRK2 | |
| SCHEMBL29514823 | 0.77 | CCND1 (0.87) | CCND1CDK6CDK4DYRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4214213-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | Prelude Therapeutics, Incorporated (US) | 2023-07-26 | — | — | EP | claimed |
| WO-2022061273-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | PRELUDE THERAPEUTICS, INCORPORATED (US) | 2022-03-24 | — | — | WO | claimed |
| EP-4214213-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | Prelude Therapeutics, Incorporated (US) | 2023-07-26 | — | — | EP | disclosed |
| WO-2022061273-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | PRELUDE THERAPEUTICS, INCORPORATED (US) | 2022-03-24 | — | — | WO | disclosed |